AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
Mari Iida(University of Wisconsin–Madison), Deric L. Wheeler(University of Wisconsin–Madison)
Cited by 16
Related Papers
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
|Molecular Cancer|2014|64
Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
|PLoS ONE|2013|27
AXL Regulates Neuregulin1 Expression Leading to Cetuximab Resistance in Head and Neck Cancer
|Research Square|2021|1